Extracellular Volume Derived from Equilibrium CT for the Prediction of Survival Outcomes in Patients with Pancreatic Ductal Adenocarcinoma
Technology in Cancer Research & Treatment · 2025
DOI: 10.1177/15330338251336032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Ju Xiong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Tomography, X-Ray Computed, Pancreatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chongqing medical scientific research project (Joint project of Chongqing Health Commission and Science and Technology Bureau.
Abstract (Originalsprache)
Objective
To assess the efficiency of extracellular volume (ECV) derived from equilibrium computed tomography (CT) in predicting recurrence-free survival (RFS) and overall survival (OS) after R0 resection of pancreatic ductal adenocarcinoma (PDAC).
Methods
This retrospective study included 83 patients who underwent CT and R0 resection between January 2016 and September 2023. The pattern of tumor recurrence and prognosis were recorded for each patient. Tumor recurrence was classified into three groups: isolated local recurrence group, distant recurrence group and censored group. The associations between the CT-ECV and clinicopathological features and recurrence pattern of PDAC were evaluated by chi-squared test. Multivariable Cox proportional-hazards models were conducted to evaluate the effects of clinical factors, CT features and CT-ECV on RFS and OS.
Results
The median RFS and OS were 10.7 and 17.1 months, respectively. On multivariate analysis, the CT-ECV and adjacent organ invasion were found to be associated with RFS (HR, 0.968, P = .017; HR, 0.453; P = .006), and only the CT-ECV was an independent prognostic factor for OS (HR, 0.968; P = .022). Low CT-ECV group was significantly associated with elevated CA19-9, larger tumor size, G3 (tumor grade) and II/III (AJCC tumor stage) ( P < .05). In the recurrence pattern analysis, the CT-ECV did not exhibit an association between local recurrence and non-local recurrence groups ( P = .455), while patients in the low CT-ECV group were more inclined to experience distant recurrence after curative surgery ( P = .037).
Conclusions
CT-ECV determined by equilibrium contrast-enhanced CT was a useful imaging biomarker for predicting distant recurrence and survival in resectable PDAC patients, which may facilitate further risk stratification and personalized care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Haotian Liu, Hongwei Liang
Förderung
- Chongqing medical scientific research project (Joint project of Chongqing Health Commission and Science and Technology Bureau
Zitieren
APA
Xiong, J., Lu, Y., Liu, H., Ji, M., Zhang, Z., Li, Y., & Liang, H. (2025). Extracellular Volume Derived from Equilibrium CT for the Prediction of Survival Outcomes in Patients with Pancreatic Ductal Adenocarcinoma. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251336032
Vancouver
Xiong J, Lu Y, Liu H, Ji M, Zhang Z, Li Y, et al. Extracellular Volume Derived from Equilibrium CT for the Prediction of Survival Outcomes in Patients with Pancreatic Ductal Adenocarcinoma. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251336032
BibTeX
@article{Xiong2025,
author = {Xiong, Ju and Lu, Yunfeng and Liu, Haotian and Ji, Mengchu and Zhang, Zhiwei and Li, Yongmei and Liang, Hongwei},
title = {Extracellular Volume Derived from Equilibrium CT for the Prediction of Survival Outcomes in Patients with Pancreatic Ductal Adenocarcinoma},
journal = {Technology in Cancer Research & Treatment},
year = {2025},
doi = {10.1177/15330338251336032}
}
EUVIMED